Tiziana Life Sciences Ltd
TLSA
$0.798
$0.00791.00%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.97M | 1.97M | 2.23M | 2.23M | 2.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.25M | 3.25M | 4.65M | 4.65M | 4.35M |
| Operating Income | -3.25M | -3.25M | -4.65M | -4.65M | -4.35M |
| Income Before Tax | -3.99M | -3.99M | -4.31M | -4.31M | -4.31M |
| Income Tax Expenses | -1.66M | -1.66M | 224.50K | 224.50K | -- |
| Earnings from Continuing Operations | -2.33M | -2.33M | -4.54M | -4.54M | -4.31M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.33M | -2.33M | -4.54M | -4.54M | -4.31M |
| EBIT | -3.25M | -3.25M | -4.65M | -4.65M | -4.35M |
| EBITDA | -3.25M | -3.25M | -4.64M | -4.64M | -4.34M |
| EPS Basic | -0.02 | -0.02 | -0.04 | -0.04 | -0.04 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.03 |
| EPS Diluted | -0.02 | -0.02 | -0.04 | -0.04 | -0.04 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.03 |
| Average Basic Shares Outstanding | 103.10M | 103.10M | 102.67M | 102.67M | 102.27M |
| Average Diluted Shares Outstanding | 103.10M | 103.10M | 102.67M | 102.67M | 102.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |